CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 104 enrolled
Drug / intervention
Ondansetron 8 mg +1 moredrug
Likely dose
Ondansetron 8 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03134612
NCT03134612Phase 2Completed
CompareCT.gov

Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection

Indonesia University·interventional·Posted May 1, 2017·Updated May 1, 2017

In Brief

A Phase 2 clinical trial evaluating Ondansetron 8 mg and Lidocain 40 mg for General Anesthesia With Propofol. Completed, enrolled 104 participants across 1 site.

Detailed Summary

This study aims to compare the effectivity between ondansetron 8 mg and lidocain 40 mg in preventing pain due to propofol injection

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGeneral Anesthesia With Propofol
CountriesIndonesia
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedMay 1, 2017
Enrollment StartJul 1, 2016
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.2 years ago

Interventions

Ondansetron 8 mgdrug

Lidocain 40 mgdrug